RNasin?? Ribonuclease InhibitorRecombinant Cat #N2511
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0447912-V3
- Awardee
- PROMEGA CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $138.60
About this award
Promega Corporation was awarded contract A207_PO-0447912-V3 by the University of Virginia on August 8, 2026, with a cumulative contract value of $138. The prime contractor will deliver RNasin Ribonuclease Inhibitor Recombinant (Catalog Number N2511), a biochemical reagent used in molecular biology applications. The contract specifies a quantity of 138 units at a unit price of $1 per unit.
The delivery location is identified as the Buyer, consistent with University of Virginia operations in Virginia. The contract represents a straightforward procurement of laboratory reagents for research or educational purposes. No specific period of performance, annual value, or additional contract terms are detailed in the available documentation.
Line items
| Item | Total |
|---|---|
| RNasin?? Ribonuclease InhibitorRecombinant Cat #N2511 | $138.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0447912-V3?
Contract A207_PO-0447912-V3 was awarded to PROMEGA CORPORATION by University of Virginia on August 8, 2026.
How much is contract A207_PO-0447912-V3 worth?
Its cumulative value is $138.60.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award